IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, ...

In understanding what makes the patient voice so essential to successful drug development, let’s take a critical eye to what ...

The clinical trial lab services provider Q2 Solutions has fallen short of its commitment to create nearly 750 jobs and invest $73 million in Research Triangle Park. A subsidiary of IQVIA, Q2 ...

IQVIA Hldgs (NYSE:IQV) underwent analysis by 12 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ...

Feb 5 (Reuters) - Healthcare data and clinical research provider IQVIA Holdings on Thursday forecast annual profit below Wall Street expectations, weighed down by higher interest costs, even as strong ...

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, and the Duke Clinical ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and ...

Feb 5 (Reuters) - Healthcare data and clinical research provider IQVIA Holdings (IQV.N), opens new tab on Thursday defended its AI strategy against analyst concerns that recent technology advances ...

Taking the targeting of oncologists likely to start treatment with CAR-T as an example, validation studies show that targeting top-scored physicians from predictive models yields precision rates of 60 ...

Ron Bruehlman to become Senior Advisor to CEO; Michael Fedock Named as New CFO “Ron has been a cornerstone of IQVIA’s transformation and growth,” said Ari Bousbib. “His strategic leadership and ...